Comparisons of drug resistance in vitro between samples from children with AML and ALL
Drug . | LC50 values . | AML . | ALL . | RR . |
---|---|---|---|---|
Cytarabine | Median | 0.46 | 0.53 | 0.9 |
P25-P75 | 0.24-1.26 | 0.27-1.36 | ||
n | 119 | 372 | ||
Daunorubicin | Median | 0.23 | 0.09 | 2.63-150 |
P25-P75 | 0.10-0.40 | 0.07-0.18 | ||
n | 113 | 496 | ||
Idarubicin | Median | 0.17 | 0.05 | 3.43-150 |
P25-P75 | 0.09-0.29 | 0.02-0.09 | ||
n | 76 | 185 | ||
Doxorubicin | Median | 0.54 | 0.30 | 1.83-150 |
P25-P75 | 0.31-0.89 | 0.14-0.42 | ||
n | 81 | 247 | ||
Aclarubicin | Median | 0.28 | 0.11 | 2.53-151 |
P25-P75 | 0.13-0.49 | 0.08-0.20 | ||
n | 21 | 71 | ||
Mitoxantrone | Median | 0.13 | 0.05 | 2.63-150 |
P25-P75 | 0.03-0.39 | 0.01-0.10 | ||
n | 102 | 256 | ||
Etoposide | Median | 7.45 | 1.52 | 4.93-150 |
P25-P75 | 2.08-21.25 | 0.67-2.70 | ||
n | 117 | 205 | ||
Teniposide | Median | 1.00 | 0.26 | 3.8 |
P25-P75 | 0.24-1.56 | 0.18-0.61 | ||
n | 12 | 299 | ||
6-Thioguanine | Median | 6.18 | 5.95 | 1.0 |
P25-P75 | 4.06-10.66 | 3.90-8.80 | ||
n | 118 | 380 | ||
6-Mercaptopurine | Median | 93.8 | 104.2 | 0.9 |
P25-P75 | 55.3-187.5 | 51.3-250.0 | ||
n | 20 | 359 | ||
Amsacrine | Median | 0.57 | 0.11 | 5.2 |
P25-P75 | 0.14-1.36 | 0.07-0.26 | ||
n | 92 | 6 | ||
4-Hydroperoxyifosfamide | Median | 12.22 | 3.48 | 3.53-150 |
P25-P75 | 6.06-14.99 | 1.46-5.98 | ||
n | 95 | 292 | ||
Thiotepa | Median | 7.61 | 1.96 | 3.93-150 |
P25-P75 | 2.48-10.93 | 0.70-2.70 | ||
n | 23 | 27 | ||
Busulfan | Median | 37.78 | 28.24 | 1.3 |
P25-P75 | 25.57-59.01 | 21.29-30.34 | ||
n | 91 | 8 | ||
Cisplatin | Median | 5.96 | 1.76 | 3.43-151 |
P25-P75 | 2.72-7.84 | 1.33-2.39 | ||
n | 20 | 20 | ||
Carboplatin | Median | 31.49 | 13.22 | 2.43-151 |
P25-P75 | 19.06-81.313-152 | 7.39-13.22 | ||
n | 4 | 57 | ||
L-Asparaginase3-153 | Median | 0.97 | 0.14 | 6.93-150 |
P25-P75 | 0.30-1.60 | 0.01-1.13 | ||
n | 99 | 458 | ||
Vincristine | Median | 3.13 | 0.71 | 4.43-150 |
P25-P75 | 0.76-24.6 | 0.31-2.76 | ||
n | 118 | 486 | ||
Vindesine | Median | 6.88 | 2.68 | 2.6 |
P25-P75 | 2.04-21.74 | 0.77-9.23 | ||
n | 15 | 103 | ||
Prednisolone | Median | >250 | 0.69 | >3603-150 |
P25-P75 | >250->250 | 0.25-52.14 | ||
n | 124 | 459 | ||
Dexamethasone | Median | >6 | 0.07 | >853-150 |
P25-P75 | >6->6 | 0.02-1.02 | ||
n | 18 | 310 |
Drug . | LC50 values . | AML . | ALL . | RR . |
---|---|---|---|---|
Cytarabine | Median | 0.46 | 0.53 | 0.9 |
P25-P75 | 0.24-1.26 | 0.27-1.36 | ||
n | 119 | 372 | ||
Daunorubicin | Median | 0.23 | 0.09 | 2.63-150 |
P25-P75 | 0.10-0.40 | 0.07-0.18 | ||
n | 113 | 496 | ||
Idarubicin | Median | 0.17 | 0.05 | 3.43-150 |
P25-P75 | 0.09-0.29 | 0.02-0.09 | ||
n | 76 | 185 | ||
Doxorubicin | Median | 0.54 | 0.30 | 1.83-150 |
P25-P75 | 0.31-0.89 | 0.14-0.42 | ||
n | 81 | 247 | ||
Aclarubicin | Median | 0.28 | 0.11 | 2.53-151 |
P25-P75 | 0.13-0.49 | 0.08-0.20 | ||
n | 21 | 71 | ||
Mitoxantrone | Median | 0.13 | 0.05 | 2.63-150 |
P25-P75 | 0.03-0.39 | 0.01-0.10 | ||
n | 102 | 256 | ||
Etoposide | Median | 7.45 | 1.52 | 4.93-150 |
P25-P75 | 2.08-21.25 | 0.67-2.70 | ||
n | 117 | 205 | ||
Teniposide | Median | 1.00 | 0.26 | 3.8 |
P25-P75 | 0.24-1.56 | 0.18-0.61 | ||
n | 12 | 299 | ||
6-Thioguanine | Median | 6.18 | 5.95 | 1.0 |
P25-P75 | 4.06-10.66 | 3.90-8.80 | ||
n | 118 | 380 | ||
6-Mercaptopurine | Median | 93.8 | 104.2 | 0.9 |
P25-P75 | 55.3-187.5 | 51.3-250.0 | ||
n | 20 | 359 | ||
Amsacrine | Median | 0.57 | 0.11 | 5.2 |
P25-P75 | 0.14-1.36 | 0.07-0.26 | ||
n | 92 | 6 | ||
4-Hydroperoxyifosfamide | Median | 12.22 | 3.48 | 3.53-150 |
P25-P75 | 6.06-14.99 | 1.46-5.98 | ||
n | 95 | 292 | ||
Thiotepa | Median | 7.61 | 1.96 | 3.93-150 |
P25-P75 | 2.48-10.93 | 0.70-2.70 | ||
n | 23 | 27 | ||
Busulfan | Median | 37.78 | 28.24 | 1.3 |
P25-P75 | 25.57-59.01 | 21.29-30.34 | ||
n | 91 | 8 | ||
Cisplatin | Median | 5.96 | 1.76 | 3.43-151 |
P25-P75 | 2.72-7.84 | 1.33-2.39 | ||
n | 20 | 20 | ||
Carboplatin | Median | 31.49 | 13.22 | 2.43-151 |
P25-P75 | 19.06-81.313-152 | 7.39-13.22 | ||
n | 4 | 57 | ||
L-Asparaginase3-153 | Median | 0.97 | 0.14 | 6.93-150 |
P25-P75 | 0.30-1.60 | 0.01-1.13 | ||
n | 99 | 458 | ||
Vincristine | Median | 3.13 | 0.71 | 4.43-150 |
P25-P75 | 0.76-24.6 | 0.31-2.76 | ||
n | 118 | 486 | ||
Vindesine | Median | 6.88 | 2.68 | 2.6 |
P25-P75 | 2.04-21.74 | 0.77-9.23 | ||
n | 15 | 103 | ||
Prednisolone | Median | >250 | 0.69 | >3603-150 |
P25-P75 | >250->250 | 0.25-52.14 | ||
n | 124 | 459 | ||
Dexamethasone | Median | >6 | 0.07 | >853-150 |
P25-P75 | >6->6 | 0.02-1.02 | ||
n | 18 | 310 |
The results are expressed in LC50 values given as μg/mL. Median indicates median LC50 values; P25, the 25th percentile; P75, the 75th percentile; n, the number of samples. RR (resistance ratio) indicates the median LC50 for AML divided by the median LC50 for ALL. RR > 1.0, indicates that for the given drug, AML is more resistant than ALL.
P ≤ .001, as determined by the Mann-WhitneyU test.
P > .001 and P ≤ .01, as determined by the Mann-Whitney U test.
The minimum to maximum range is given, rather than P25-P75.
l-asparaginase is given as IU/mL, not as μg/mL.